Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexandrow

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Plos One|March 11, 2011
Cdc45 limits replicon usage from a low density of preRCs in mammalian cellsPhilip G Wong, Sherry L Winter, Elena Zaika, et al.
Molecular Cancer Therapeutics|July 10, 2024
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome FunctionShengyan Xiang, Kendall C Craig, Xingju Luo, et al.
Molecular Immunology|September 1, 2017
Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survivalLou-Ella M M Alexander, January Watters, Jessica A Reusch, et al.
Data in Brief|October 13, 2017
Data supporting the functional role of Eleven-nineteen Lysine-rich Leukemia 3 (ELL3) in B cell lymphoma cell line cellsLou-Ella M M Alexander, January Watters, Jessica A Reusch, et al.
Cancer|March 17, 2020
An evolutionary framework for treating pediatric sarcomasDamon R Reed, Jonathan Metts, Mariyah Pressley, et al.
Scientific Reports|November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapyDarcy L Welch, Brooke L Fridley, Ling Cen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Plos One|March 11, 2011
Cdc45 limits replicon usage from a low density of preRCs in mammalian cellsPhilip G Wong, Sherry L Winter, Elena Zaika, et al.
Molecular Cancer Therapeutics|July 10, 2024
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome FunctionShengyan Xiang, Kendall C Craig, Xingju Luo, et al.
Molecular Immunology|September 1, 2017
Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survivalLou-Ella M M Alexander, January Watters, Jessica A Reusch, et al.
Data in Brief|October 13, 2017
Data supporting the functional role of Eleven-nineteen Lysine-rich Leukemia 3 (ELL3) in B cell lymphoma cell line cellsLou-Ella M M Alexander, January Watters, Jessica A Reusch, et al.
Cancer|March 17, 2020
An evolutionary framework for treating pediatric sarcomasDamon R Reed, Jonathan Metts, Mariyah Pressley, et al.
Scientific Reports|November 18, 2023
Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapyDarcy L Welch, Brooke L Fridley, Ling Cen, et al.
Pageof 4